Cre Drug Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2020.
2020 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Cre Drug Private Limited

Cre Drug Private Limited, a struck off private limited company, was established on 25 August 2020 in Hyderabad, Telangana, India. Engaging in fine chemicals and other chemical products within the chemicals sector, it holds CIN: U24299TG2020PTC143167. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sumanth Vaddempudi (Director), Ganeshvaran Vijayaratnam (Director), Dangeti Karthik (Director). It is based at Flat No 311 Manjeera Trinity Corporate Jntu Road Kphb Colony, Hyderabad, Telangana, 500072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299TG2020PTC143167

  • Registration Number

    143167

  • Incorporation Date

    25 August 2020

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 7 Months
Company report

Cre Drug Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cre Drug Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cre Drug Private Limited?
Current Directors
Name Designation Appointment Date Status
Sumanth Vaddempudi Director 25 Aug 2020 Current
Ganeshvaran Vijayaratnam Director 25 Aug 2020 Current
Dangeti Karthik Director 25 Aug 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cre Drug.

Enhance accessibility to Cre Drug's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Cre Drug revenue growth over time
Cre Drug profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cre Drug?

Unlock access to Cre Drug's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Cre Drug?

Cre Drug has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cre Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cre Drug's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cre Drug
Recent Activity within the Organization
  • Director Appointment

    Sumanth Vaddempudi was appointed as a Director was appointed as a Director on 25 Aug 2020 & has been associated with this company since 5 years 7 months . was recorded as a recent event.

  • Director Appointment

    Ganeshvaran Vijayaratnam was appointed as a Director was appointed as a Director on 25 Aug 2020 & has been associated with this company since 5 years 7 months . was recorded as a recent event.

  • Director Appointment

    Progress on Dangeti Karthik was appointed as a Director was appointed as a Director on 25 Aug 2020 & has been associated with this company since 5 years 7 months . was documented.

  • Company Incorporation

    Cre Drug Private Limited was registered on 25 Aug 2020 with Roc Hyderabad & aged 5 years 7 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cre Drug Private Limited?

The CIN of Cre Drug Private Limited is U24299TG2020PTC143167.

Where is Cre Drug Private Limited headquartered?

Cre Drug Private Limited is headquartered at Flat No 311 Manjeera Trinity Corporate Jntu Road Kphb Colony, Hyderabad, Telangana, 500072.

When was Cre Drug Private Limited incorporated?

Cre Drug Private Limited was incorporated on 25 August 2020.

Who are the current directors of Cre Drug Private Limited?

The current directors of Cre Drug Private Limited are

What is the primary industry of Cre Drug Private Limited?

The primary industry of Cre Drug Private Limited is Chemicals.

Is Cre Drug Private Limited a listed company?

Cre Drug Private Limited is unlisted.

What is the capital structure of Cre Drug Private Limited?

The authorized capital of Cre Drug Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available